Expert CTD Dossier preparation, review, and submission services for pharmaceutical, medical device, and cosmetic product registration with the Ethiopian Food and Drug Authority (EFDA). From dossier writing to final approval - Medwisdom manages it all.
Medwisdom Lifescience is a trusted provider of CTD Dossier writing, review, and regulatory submission services for the Ethiopian market. We support pharmaceutical manufacturers, importers, exporters, and distributors seeking product registration with the Ethiopian Food and Drug Authority (EFDA).
The Common Technical Document (CTD) is an internationally harmonized format developed by the International Council for Harmonisation (ICH) to streamline pharmaceutical regulatory submissions globally. EFDA has adopted the CTD format as the standard for marketing authorization applications, requiring applicants to present clinical, quality, and safety data in a structured, reviewer-friendly manner.
EFDA Ethiopia requires a complete CTD submission covering all five modules. Here is a clear breakdown of what each module must contain.
Country-specific administrative documents including the EFDA application form, product monograph, proposed labeling, patient information leaflet, and certificates such as CPP (Certificate of Pharmaceutical Product). Content must comply with Ethiopian national regulations.
Comprehensive scientific summaries of quality, non-clinical, and clinical data. Includes the Quality Overall Summary (QOS), Non-clinical Overview, Clinical Overview, and tabulated summaries - providing EFDA reviewers with a high-level view of the entire dossier.
Detailed pharmaceutical quality data covering drug substance (Active Pharmaceutical Ingredient) and drug product. Includes specifications, manufacturing processes, characterization, stability studies, and container-closure system data per ICH Q-guidelines.
Pharmacological and toxicological study reports including pharmacokinetics, genotoxicity, carcinogenicity, reproductive toxicity, and local tolerance studies. Data must be compiled per ICH S-series guidelines to support product safety in the Ethiopian population.
All clinical data supporting efficacy and safety, including bioavailability and bioequivalence (BA/BE) studies for generics, Phase I–III clinical trial reports, post-marketing surveillance data, and literature references demonstrating established therapeutic use.
EFDA may require additional local documentation such as GMP certificates from the country of manufacture, free-sale certificates, and import permits. Medwisdom ensures full compliance with all EFDA-specific requirements alongside the standard CTD format.
A structured, end-to-end approach that reduces timelines and maximizes first-cycle approval rates.
Review existing data, identify documentation gaps, and map EFDA requirements
Compile all 5 CTD modules in EFDA-accepted eCTD or NeeS format
Internal expert review for completeness, consistency, and regulatory accuracy
Formal submission to the Ethiopian Food and Drug Authority with follow-up support
Timely, expert responses to EFDA technical queries and deficiency letters
Marketing Authorization Certificate issued - your product is ready for the Ethiopian market
We provide comprehensive regulatory support across pharmaceuticals, medical devices, and cosmetics to help your products achieve and maintain EFDA compliance.
End-to-end marketing authorization support for medicines, generics, biologics, and OTC products under EFDA Ethiopia guidelines.
Guidance through EFDA medical device licensing, risk classification, technical file preparation, and conformity assessment documentation.
Preparation and submission of cosmetic product notifications to EFDA, including ingredient compliance checks and safety assessments.
Compilation and submission of CTAs to EFDA and relevant ethics committees, with full protocol support and regulatory follow-up.
Local pharmacovigilance system setup, adverse event reporting, PSUR submissions, and risk management plan development for Ethiopia.
Management of product variations, amendments, license renewals, and post-approval changes to EFDA-registered products.
Support for EFDA GMP inspections, site readiness assessments, documentation preparation, and GMP certification guidance.
Review and optimization of product labels, patient information leaflets, and packaging artwork to meet EFDA regulatory requirements.
Support for EFDA import/export permits, Section 21 authorizations, batch release certificates, and customs compliance for regulated products.
Tailored regulatory roadmaps, market entry strategy, and lifecycle management planning for the Ethiopian pharmaceutical market.
Preparation of comprehensive safety/efficacy summaries, gap analyses, and supporting scientific documentation for EFDA registration dossiers.
Assistance with pharmacy establishment licenses, wholesale/distributor permits, and related EFDA authorization requirements.
We combine deep regulatory expertise with a client-first approach to deliver consistent, high-quality results.
Extensive experience navigating EFDA and African regulatory frameworks for pharmaceuticals and medical devices.
Beyond Ethiopia, we support registrations across 40+ countries, enabling seamless regional market expansion.
Qualified regulatory scientists, medical writers, and pharmacovigilance specialists assigned to every project.
Milestone-driven project management ensures your dossier is submission-ready within agreed timelines.
Regular project updates, clear fee structures, and dedicated point-of-contact throughout your registration journey.
Our rigorous internal QC process minimizes EFDA queries and deficiency letters, accelerating time-to-market.
Answers to the most common questions about pharmaceutical registration in Ethiopia.